Viewing Study NCT01583218


Ignite Creation Date: 2025-12-25 @ 4:50 AM
Ignite Modification Date: 2026-04-24 @ 4:45 AM
Study NCT ID: NCT01583218
Status: COMPLETED
Last Update Posted: 2023-08-07
First Post: 2012-04-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Sponsor: Portola Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Venous Thromboembolism (VTE) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase III View